Depressive symptoms and quality of life in adolescents with type 2 diabetes: baseline data from the TODAY study

Diabetes Care. 2011 Oct;34(10):2205-7. doi: 10.2337/dc11-0431. Epub 2011 Aug 11.

Abstract

Objective: The study objective was to examine the prevalence of depressive symptoms and relationships to quality of life and demographics in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study's large, ethnically diverse youth with type 2 diabetes.

Research design and methods: A total of 704 youth with type 2 diabetes <2 years' duration, aged 10-17 years, and BMI ≥85th percentile completed depressive symptoms and quality of life measures.

Results: Some 14.8% reported clinically significant depressive symptoms, and older girls had significantly higher rates than older boys.

Conclusions: Rates of significant depressive symptoms were similar to those of healthy adolescents and lower than those of teens with type 1 diabetes. Elevated depressive symptoms, particularly in older girls, suggest clinicians assess vulnerability.

Trial registration: ClinicalTrials.gov NCT00081328.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Age Factors
  • Child
  • Depression / diagnosis*
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Diabetes Mellitus, Type 2 / psychology*
  • Female
  • Humans
  • Male
  • Quality of Life*
  • Sex Factors

Associated data

  • ClinicalTrials.gov/NCT00081328

Grant support